1 Evaluation of Acute Bronchodilator Reversibility in Symptomatic GOLD Stage I COPD Authors: Denis E. O’Donnell 1 , Pierantonio Laveneziana 1 , Josuel Ora 1 , Katherine A. Webb 1 , Yuk-Miu Lam 2 , Dror Ofir 1 . Institution: 1 Respiratory Investigation Unit, Department of Medicine, Queen’s University and Kingston General Hospital, Kingston, Ontario, Canada. 2 Department of Community Health and Epidemiology, Queen’s University, Kingston, Ontario, Canada. Correspondence to: Dr. Denis O’Donnell 102 Stuart Street Kingston, Ontario, Canada K7L 2V6 tel: 1 (613) 548-2339 fax: 1 (613) 549-1459 e-mail: odonnell@queensu.ca The corresponding authors has the right to grant on behalf of all authors and does grant on behalf of all authors, an exclusive licence on a worldwide basis to the BMJ Publishing Group Ltd to permit this article (if accepted) to be published in THORAX and any other BMJPGL products and sublicences such as and exploit all subsidiary rights, as set out in our licence (http://thorax.bmjjournals.com/misc/ifora/licenceform.shtml). Running head: Effects of ipratropium in mild COPD Key words: exercise, lung hyperinflation, dyspnoea, anticholinergic, efficacy. Thorax Online First, published on December 3, 2008 as 10.1136/thx.2008.103598 Copyright Article author (or their employer) 2008. Produced by BMJ Publishing Group Ltd (& BTS) under licence. on June 7, 2020 by guest. Protected by copyright. http://thorax.bmj.com/ Thorax: first published as 10.1136/thx.2008.103598 on 3 December 2008. Downloaded from